期刊文献+

玻璃体腔注射雷珠单抗联合小梁切除术治疗新生血管性青光眼疗效观察 被引量:25

The treatment of neovascular glaucoma by intravitreous injection of Lucentis combined with trabeculectomy and mitomycin C
在线阅读 下载PDF
导出
摘要 目的观察玻璃体腔注射雷珠单抗(Lucentis)联合复合式小梁切除术治疗新生血管性青光眼的疗效。方法对17例(17只眼)新生血管性青光眼行玻璃体腔注射Lucentis 0.50 mg/0.05 ml,8~14 d后行复合式小梁切除术。观察玻璃体腔注射Lucentis后虹膜及房角新生血管消退的时间、眼压的变化以及复合式小梁切除术后视力和眼压的变化。术后随访8~12个月。结果玻璃体腔注射Lucentis后,13只眼虹膜新生血管1周内完全消退,4只眼2二周内完全消退。注药前平均眼压(39.56±10.12)mm Hg,注药后1周平均眼压(38.62±8.35)mm Hg与注药前比较眼压变化无统计学意义(t=0.951,P〉0.05)。小梁切除术后1周眼压(10.43±6.12)mm Hg,最后一次随访眼压(13.61±4.31)mm Hg,与术前比较差异均有统计学意义(t=21.362、19.817,P均﹤0.01)。末次随访时12只眼视力提高,5只眼视力未变。结论玻璃体腔注射雷珠单抗联合复合式小梁切除术能有效地控制眼压,保护视功能。 Objective To observe the effect of Lucentis intravitrcous injection combined with ulectomy and MMC administration on neovascular glaucoma (NVG). Methods Seventeen eyes of 17 patients with angle-elesure NVG were treated with intravitreous injection of Lucentis 0.50m8/0.05ml. Trabeculectomy were performed in 8 ± 14 days with MMC application. The regression of iris neovascularization and changes in intraocular pressure ( IOP ) were observed after the injection. Best corrected visual acuity was followed after trabeculectomy. Patients were followed-up for 8 - 12 months. Results Irls neovascularizatlon completely regressed within one week in 13 eyes and within 2 weeks in the other 4 eyes af- ter the injection of Lucentis. The average IOP was ( 39.56 ± 10. 12 ) mm Hg before injection, and ( 38.62 ± 8.35 ) mm- Hg in a week after injection. The IOP had no significant changes before and after injection ( t = 0.951, P 〉 0. 05 ). The IOP was ( 10.43 ± 6. 12 ) mmHg in one week after traboculectomy, and ( 13.61 ± 4.31 ) mmHg in the last follow-up vis- it. Compared with the preoperative measurements, there was a significant reduction in IOP ( t = 21.362 at 1 week, t = 19. 817 at 2 weeks, both P 〈 0.01 ). The best corrected visual acuity improved in 12 eyes, remained unchanged in 5 eyes at eyes follow-up visit. Conclusion Intravitreous injection of Lucentis combined with trabeculectomy and MMC application could effectively control the IOP and pteserve the visual function in patients with neovascular glaucoma.
出处 《临床眼科杂志》 2014年第6期543-545,共3页 Journal of Clinical Ophthalmology
关键词 新生血管性青光眼 玻璃体腔注射 雷珠单抗 小梁切除术 Neovssculsr g1aucoma Intravitreal Lucentis Trabectomy Mitomycin C
  • 相关文献

参考文献6

  • 1Yildirim N, Yalvac IS, Sahin A, et al. A cempara6ve study be- tween diode laser cyclophotoeo and the ahmed Slaueea valve/mphant in neovascu]ar glaucoma: a long-term follow-up . J glaucoma ,2009,18:192-196.
  • 2Moraczewski AL,Lee RK,Palmberg PF,et al. Outcomes of treat- ment of neovasenler glaneoma with intmv/trenl bevaelmmab. Br J Ophthalmol,2009 ,93 :589-593.
  • 3Grover S, Gupta S, Shanna R,et al. lntmcmneral bevaclmmab d- feetively reduces aqueous vascular endothelial growth fseter eon- centrafiens in neovascular glaucoma . Br J Ophthalmol,2009,93: 273-274.
  • 4Pleramici DJ,Avery RL. Ranibi,,mAh: trentment in patients with neovasmlar a--related maeular degeneration, Opin Biol T- her 2006,6:1237-1245.
  • 5梁勇,赵明威,潘中婷,侯宪如,任泽钦,黎晓新.新生血管性青光眼治疗策略的初步探讨[J].中国实用眼科杂志,2011,29(3):231-235. 被引量:29
  • 6AL Obeidan SA, Oman EA, AL-Amm SA, et al. Full preopera- five panretml phococoagulafion improves the outcome of tmbecu- leetomy -ith mitomycin C for neovssoular glaucoma. Eur J Oph- thalmol,2008 ,18 :758-76.

二级参考文献7

  • 1Sivak-Callcott JA, O'Day DM, Tsai JC, et al.Evidencebased recom-mendations for the Diagnosis and treatment of Neovascular Glaucoma [J]. Ophthalmology, 2001,108 (10): 1767-1778.
  • 2Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases[J]. Ophthalmology. 2008,115(9):1571-1580.
  • 3Jaissle GB, Szurman P, Bartz-Schmidt KU, et al. Recommendation for the implementation of intravitreal injections-statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA) [J]. Klin Monatsbl Augenheilkd, 2005, 222(5 ):390-395.
  • 4Ming-Wei Zhao, Peng Zhou, Xuan Cui, et al. Manual Small Incision 20-Gauge Pars Plana Vitrectomy[J]. retina. 2009,29 ( 9 ): 1364-1366.
  • 5Tsai JC, Feuer WJ, Parrish RK II, et al. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study[J]. Ophthalmology, 1995, 102(6):887-892.
  • 6Caprioli J, Strang SL, Spaeth GL, et al. Cyclocryotherapy in the treatment of advanced glaucoma[J]. Ophthalmology, 1985,92 (7):947-954.
  • 7Hamard P, Baudouin C. Consensus on neovascular glaucoma [J]. J Fr Ophthahnol, 2000, 23 (3): 289-294.

共引文献28

同被引文献159

  • 1黄圣松,余敏斌,方敏,郭疆.原发性急性闭角型青光眼高眼压下的小梁切除术[J].中国实用眼科杂志,2004,22(11):885-888. 被引量:98
  • 2李裕钦,薛雨顺,车选义,赵欣,韩碧琴.新生血管性青光眼的手术治疗[J].眼科新进展,2005,25(4):358-358. 被引量:45
  • 3徐韶琳,王英,高志卓,尹元,刘晔.小梁切除术+睫状体冷冻术+全周边视网膜冷凝术治疗新生血管性青光眼[J].中国实用眼科杂志,2006,24(12):1309-1310. 被引量:13
  • 4Ryoo NK, Lee EJ, Kim TW. Regression of iris neovascularization after subconjunctival injection of bevacizumab. Korean J Ophthalmol ,2013 ,27 (4) :299-303.
  • 5Kabesha TB, Glacet - Bernard A, Rostaqui O, et al . Anti - VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion. J Fr Ophtalmol ,2015 ,38(5 ) :414-4,20.
  • 6樊会霞,刘玉新.玻璃体腔内注射雷珠单抗治疗新生血管性青光眼24例的疗效观察[J].检验医学与临床,2014(z1):315-317.
  • 7Yu XB, Sun XH, Dahan E. Increased levels of transforming growth factor- betal and- beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imag 2007 ;38 ( 1 ) :6-14.
  • 8Grover S, Gupta S, Sharma R. Intracameralbevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma. 13r J Ophthalmol 2009 ;93 (2) :273-274.
  • 9张舒心,唐忻,刘磊,陈虹,等.青光眼手术失败的原因、预防及处理[J].青光眼治疗学,2011,1(2):319.335.
  • 10樊会霞,刘玉新.玻璃体腔内注射雷珠单抗治疗新生血管性青光眼24例的疗效观察[J].检验医学与临床,2014,11(z1):162.

引证文献25

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部